KASANDRA LECHEL: Open Payments
NPI 1306954334 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 33 payments from 16 companies in 2025. Trend: 2023 $307 · 2024 $481 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $138 |
| Otsuka America Pharmaceutical, Inc. | 3 | $82 |
| ABBVIE INC. | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $62 |
| Corcept Therapeutics | 2 | $58 |
| Novo Nordisk Inc | 3 | $47 |
| Viatris Specialty LLC | 2 | $46 |
| Amgen Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $34 |
| Abbott Laboratories | 1 | $29 |
Products named: REXULTI, AIRSUPRA, CAPLYTA, Korlym, VRAYLAR, YUPELRI, BREZTRI, JARDIANCE.
Industry payments across MI — which companies pay providers there.
